Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy

Completed · Not applicable · Has a placebo group

Conditions studied: Asthma

In brief

This study will investigate sublingual immunotherapy (SLIT), a treatment involving antigens placement under the tongue to help asthma sufferers build a tolerance to the allergy-causing substances. Specifically, this study will determine the effectiveness of SLIT at two different dosing regimens for patients with intermittent mild asthma caused by dust mites.

Key facts

Study ID

NCT00200850

Run by

University of Wisconsin, Madison

People needed

31

Starts

2006-01-01

Expected to finish

2008-10-01

Last updated by the study team

2019-06-12

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• House dust mite-induced allergic rhinitis/mild intermittent asthma

You may not qualify if…

• Use of previous allergy immunotherapy for house dust mite asthma
• Pregnancy or breastfeeding

Where it is running

• University of Wisconsin Medical School — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.